scPharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on the development of subcutaneous furosemide and a cephalosporin antibiotic products for the treatment of worsening and heart failure of inpatient setting. scPharmaceuticals serves patients in the State of Massachusetts.

Investor Presentation

Corporate Presentation

United States

Optinose, Inc. offers health care services. The Hospital offers ear, nose, and throat surgery, as well as provides treating of nasal and sinus diseases, research, development, medication of migraine, clinical data analysis, diagnosis, and other services. Optinose operates worldwide.

Bakhu Holdings, Corp. focuses on the Bio-pharmacy field specifically in the cell-extraction sector. The Company is based in the United States.

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of antibiotics. The Company develops medicine for serious community-acquired bacterial infections. Paratek Pharmaceuticals' products treat patients in both the community and hospital setting.

NGM Biopharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing novel therapeutics based on scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic, and ophthalmic diseases. NGM Biopharmaceuticals serves medical industry in the United States.

Aclaris Therapeutics, Inc. operates as a clinical-stage specialty pharmaceutical company. The Company focuses on identifying, developing, and commercialization topical drugs to address significant unmet needs in dermatology. Aclaris Therapeutics offers a topical therapy for the treatment of seborrheic keratosis and other verrucoid lesions of the skin.

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company develops next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. Zynerba Pharmaceuticals serves the healthcare sector and patients in the United States.

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.  The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.

Assembly Biosciences Inc. is a biopharmaceutical company. The Company is focused in the field of infectious diseases such as the Hepatitis B virus (HBV) and clostridium difficile (CDAD). Assembly is developing two proprietary platforms: an HBV-cure platform focused on oral drugs with novel direct-acting mechanisms, and an orally-delivered microbiome therapeutics platform for treating CDAD.

Odonate Therapeutics, Inc. operates as a pharmaceutical company. The Company develops an oral chemotherapy drugs for the treatment of cancer. Odonate Therapeutics offers its services worldwide.

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company develops, discovers, and commercializes aesthetics and dermatology based products for inflammatory skin diseases, tissue injury, and unwanted light-pigmented hair reduction. Sienna Biopharmaceuticals serves patients in the United States and Italy.

Sam-A Pharmaceutical Co., Ltd. develops and manufactures a variety of medical and pharmaceutical products.  The Company's products include medicines for cold and fever, inflammatory, allergy, nutrition, and respiratory and digestive systems.  Sam-A specializes in medicines for infants and children.

Il Yang Pharmaceutical Co., Ltd. manufactures a wide range of drugs acting on the digestive system, respiratory system, and circulatory system.  The Company also produces antipyretic, analgesic, anti-inflammatory, and nutritional agents, tranquilizers, health food, insecticides, cosmetics, pharmaceutical raw materials, and therapeutic agents for liver and kidney disease.

Lincoln Pharmaceuticals Limited manufactures therapeutic products. The Company also manufactures dosage forms like tablets, capsules, injectables, syrups, ointments.

Samjin Pharmaceutical Co., Ltd. produces antipyretic, analgesic, circulatory, anti-inflammatory, gastrointestinal, herbal tonic, and hepatic pharmaceutical products.  The Company also manufactures respiratory, antibiotic, anti-cancer, and detoxifying medications.

Samjin Pharmaceutical Co, Ltd. (005500 KS)

JW Holdings Corporation is a holding company, which operates pharmaceutical companies, biotechnology companies, and automotive parts manufacturing companies.

Sichuan Languang Development Co. Ltd. engages in manufacturing and sales of various medications. These products are mainly for paediatrics, gynaecology and skin disease treatment. The Company also manufactures medical equipments and pharmaceutical raw materials.

Nang Kuang Pharmaceutical Co., Ltd. manufactures a wide range of pharmaceutical products. The Company key products includes key products including large volume parenterals, aseptic parenterals, lyophilized injection, pre-filled syringe and tablets, capsules, topical products, oral suspensions etc.

Whanin Pharmaceutical Co., Ltd. manufactures medical drugs.  The Company produces medicines used to treat mental disorder, fever, liver disorder, and alcohol addiction.  Whanin Pharmaceutical also produces antibiotics and multi-vitamins.

Taiko Pharmaceutical Co Ltd is a pharmaceutical company that manufactures and sells gastrointestinal pharmaceuticals and general use pharmaceutical products.

Probiotec Ltd. manufactures over-the-counter pharmaceuticals and complementary products.  The Company also contract manufactures prescription, over-the-counter, and neutraceutical products for third parties.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00